James S. Terry

ORCID: 0000-0001-7003-8862
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • vaccines and immunoinformatics approaches
  • Monoclonal and Polyclonal Antibodies Research
  • SARS-CoV-2 detection and testing
  • Glycosylation and Glycoproteins Research
  • Biosensors and Analytical Detection
  • Advanced biosensing and bioanalysis techniques
  • RNA and protein synthesis mechanisms
  • SARS-CoV-2 and COVID-19 Research
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Viral gastroenteritis research and epidemiology

Colorado State University
2020-2025

University of Colorado Anschutz Medical Campus
2024

Point-of-care (POC) methods currently available for detecting SARS-CoV-2 infections still lack accuracy. Here, we report the development of a highly sensitive electrochemical immunoassay capable quantitatively presence virus in patient nasopharyngeal samples using stencil-printed carbon electrodes (SPCEs) functionalized with capture antibodies targeting nucleocapsid protein (N protein). Samples are added to electrode surface, followed by horseradish peroxidase (HRP)-conjugated detection also...

10.1021/acs.analchem.1c04966 article EN Analytical Chemistry 2022-03-09

Defining the binding epitopes of antibodies is essential for understanding how they bind to their antigens and perform molecular functions. However, while determining linear monoclonal can be accomplished utilizing well-established empirical procedures, these approaches are generally labor- time-intensive costly. To take advantage recent advances in protein structure prediction algorithms available scientific community, we developed a calculation pipeline based on localColabFold...

10.7554/elife.98369.2 preprint EN 2025-01-23

A capillary-driven microfluidic sequential flow device, designed for eventual at-home or doctor's office use, was developed to perform an enzyme-linked immunosorbent assay (ELISA) serology assays.

10.1039/d3ay00225j article EN cc-by-nc Analytical Methods 2023-01-01

Defining the binding epitopes of antibodies is essential for understanding how they bind to their antigens and perform molecular functions. However, while determining linear monoclonal can be accomplished utilizing well-established empirical procedures, these approaches are generally labor-and time-intensive costly. To take advantage recent advances in protein structure prediction algorithms available scientific community, we developed a calculation pipeline based on localColabFold...

10.7554/elife.98369.1 preprint EN 2024-06-11

Abstract The global COVID-19 pandemic has caused massive disruptions in every society around the world. To help fight COVID-19, new molecular tools specifically targeting critical components of causative agent SARS-Coronavirus-2 (SARS-CoV-2), are desperately needed. SARS-CoV-2 nucleocapsid protein is a major component viral replication processes, integral to particle assembly, and diagnostic marker for infection immune protection. Currently available antibody reagents were primarily...

10.1101/2020.09.03.280370 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2020-09-03

Defining the binding epitopes of antibodies is essential for understanding how they bind to their antigens and perform molecular functions. However, while determining linear monoclonal can be accomplished utilizing well-established empirical procedures, these approaches are generally labor-and time-intensive costly. To take advantage recent advances in protein structure prediction algorithms available scientific community, we developed a calculation pipeline based on localColabFold...

10.7554/elife.98369 preprint EN 2024-06-11

Defining the binding epitopes of antibodies is essential for understanding how they bind to their antigens and perform molecular functions. However, while determining linear monoclonal can be accomplished utilizing well-established empirical procedures, these approaches are generally labor- time-intensive costly. To take advantage recent advances in protein structure prediction algorithms available scientific community, we developed a calculation pipeline based on localColabFold...

10.1101/2024.04.19.590298 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2024-04-19

A disposable enzyme-linked immunosorbent assay (dELISA) device for ate-home or doctor’s office use was developed to detect SARS-CoV-2 antibodies. Serology testing antibodies is currently run using well-plate ELISAs in centralized laboratories. However, the scale of serology needed epidemiological and clinical screening studies will overwhelm existing laboratory resources. Instead, a point-of-need that can be used at home offices COVID-19 must one four target products prioritized by World...

10.33774/chemrxiv-2021-c4bmd-v3 preprint EN cc-by-nc-nd 2021-10-20
Coming Soon ...